{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:02:58Z","timestamp":1784894578106,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIDA","award":["K23DA044874"],"award-info":[{"award-number":["K23DA044874"]}]},{"name":"NIDA","award":["DP2DA056107"],"award-info":[{"award-number":["DP2DA056107"]}]},{"name":"NIDA","award":["K23DA060719"],"award-info":[{"award-number":["K23DA060719"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10461-026-05049-x","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T04:44:24Z","timestamp":1770007464000},"page":"2242-2255","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PrEPSteps: A Pilot Randomized Controlled Trial to Assess the Feasibility and Acceptability of a Digital Pill-Based PrEP Adherence Intervention in Men Who Have Sex with Men with Substance Use Disorder"],"prefix":"10.1007","volume":"30","clinical-trial-number":[{"clinical-trial-number":"nct03512418","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-4117","authenticated-orcid":false,"given":"Peter R.","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia R.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Albrechta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Hokayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassir","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany R.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle K.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Buffkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Carnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conall","family":"O\u2019Cleirigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"5049_CR1","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587\u201399.","journal-title":"N Engl J Med"},{"key":"5049_CR2","unstructured":"CDC. Clinical Guidance for PrEP. HIV Nexus: CDC Resources for clinicians https:\/\/www.cdc.gov\/hivnexus\/hcp\/prep\/index.html (2024)."},{"key":"5049_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/QAI.0000000000002407","volume":"85","author":"CN Okafor","year":"2020","unstructured":"Okafor CN, et al. Brief report: associations between self-reported substance use behaviors and PrEP acceptance and adherence among Black MSM in the HPTN 073 study. JAIDS J Acquir Immune Defic Syndr. 2020;85:23\u20139.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"5049_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/09540121.2017.1360992","volume":"30","author":"EF Closson","year":"2018","unstructured":"Closson EF, Mitty JA, Malone J, Mayer KH, Mimiaga MJ. Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study. AIDS Care. 2018;30:191\u20138.","journal-title":"AIDS Care"},{"key":"5049_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/COH.0000000000000597","volume":"15","author":"ME Clement","year":"2020","unstructured":"Clement ME, Kofron R, Landovitz RJ. Long-acting injectable cabotegravir for the prevention of HIV infection. Curr Opin HIV AIDS. 2020;15:19\u201326.","journal-title":"Curr Opin HIV AIDS"},{"key":"5049_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/COH.0000000000000733","volume":"17","author":"MA Spinelli","year":"2022","unstructured":"Spinelli MA, Grinsztejn B, Landovitz RJ. Promises and challenges: cabotegravir for preexposure prophylaxis. Curr Opin HIV AIDS. 2022;17:186\u201391.","journal-title":"Curr Opin HIV AIDS"},{"key":"5049_CR7","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1016\/S2352-3018(23)00079-6","volume":"10","author":"JE Haberer","year":"2023","unstructured":"Haberer JE, Mujugira A, Mayer KH. The future of HIV pre-exposure prophylaxis adherence: reducing barriers and increasing opportunities. Lancet HIV. 2023;10:e404\u201311.","journal-title":"Lancet HIV"},{"key":"5049_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa2407001","volume":"391","author":"L-G Bekker","year":"2024","unstructured":"Bekker L-G, et al. Twice-yearly lenacapavir or daily F\/TAF for HIV prevention in cisgender women. N Engl J Med. 2024;391:1179\u201392.","journal-title":"N Engl J Med"},{"key":"5049_CR9","unstructured":"Office of Infectious Disease and HIV\/AIDS Policy. Ending the HIV Epidemic. HIV.gov https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/overview (2023)."},{"key":"5049_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12529-019-09786-3","volume":"26","author":"TR Glynn","year":"2019","unstructured":"Glynn TR, et al. Pathways to health: an examination of HIV-related stigma, life stressors, depression, and substance use. Int J Behav Med. 2019;26:286\u201396.","journal-title":"Int J Behav Med"},{"key":"5049_CR11","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0005-7967(00)00091-7","volume":"39","author":"SA Safren","year":"2001","unstructured":"Safren SA, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39:1151\u201362.","journal-title":"Behav Res Ther"},{"key":"5049_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cbpra.2016.02.004","volume":"24","author":"SW Taylor","year":"2017","unstructured":"Taylor SW, et al. \u2018Life-Steps\u2019 for PrEP Adherence: demonstration of a CBT-based intervention to increase adherence to preexposure prophylaxis (PrEP) medication among sexual-minority men at high risk for HIV acquisition. Cogn Behav Pract. 2017;24:38\u201349.","journal-title":"Cogn Behav Pract"},{"key":"5049_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11904-020-00502-5","volume":"17","author":"MA Spinelli","year":"2020","unstructured":"Spinelli MA, et al. Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions. Curr HIV\/AIDS Rep. 2020;17:301\u201314.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"5049_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13181-015-0494-8","volume":"11","author":"PR Chai","year":"2015","unstructured":"Chai PR, et al. Utilizing an ingestible biosensor to assess real-time medication adherence. J Med Toxicol. 2015;11:439\u201344.","journal-title":"J Med Toxicol"},{"key":"5049_CR15","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1097\/QAI.0000000000002854","volume":"89","author":"PR Chai","year":"2022","unstructured":"Chai PR, et al. DigiPrEP: a pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure prep adherence in men who have sex with men who use substances. J Acquir Immune Defic Syndr. 2022;89:e5\u201315.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"5049_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciac280","volume":"76","author":"SH Browne","year":"2023","unstructured":"Browne SH, et al. Supporting the art: medication adherence patterns in persons prescribed ingestible sensor-enabled oral pre-exposure prophylaxis to prevent human immunodeficiency virus infection. Clin Infect Dis. 2023;76:134\u201343.","journal-title":"Clin Infect Dis"},{"key":"5049_CR17","first-page":"12","volume":"13","author":"GP Flores","year":"2016","unstructured":"Flores GP, et al. Performance, reliability, usability, and safety of the id-cap system for ingestion event monitoring in healthy volunteers: a pilot study. Innov Clin Neurosci. 2016;13:12\u20139.","journal-title":"Innov Clin Neurosci"},{"key":"5049_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/tbm\/ibab117","author":"PR Chai","year":"2022","unstructured":"Chai PR, et al. Development of a digital pill and respondent behavioral intervention (PrEPSteps) for HIV pre-exposure prophylaxis adherence among stimulant using men who have sex with men. Transl Behav Med. 2022. https:\/\/doi.org\/10.1093\/tbm\/ibab117.","journal-title":"Transl Behav Med"},{"key":"5049_CR19","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s10461-022-03594-9","volume":"26","author":"PR Chai","year":"2022","unstructured":"Chai PR, et al. Real-world user experiences with a digital pill system to measure PrEP adherence: perspectives from MSM with substance use. AIDS Behav. 2022;26:2459\u201368.","journal-title":"AIDS Behav"},{"key":"5049_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-024-04435-7","author":"PR Chai","year":"2024","unstructured":"Chai PR, et al. Leveraging a digital pill system to understand prevention-effective adherence to oral Hiv pre-exposure prophylaxis among men who have sex with men with substance use. AIDS Behav. 2024. https:\/\/doi.org\/10.1007\/s10461-024-04435-7.","journal-title":"AIDS Behav"},{"key":"5049_CR21","unstructured":"Food and Drug Administration. 510K Premarket Notification eTectRx. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K183052 (2019)."},{"key":"5049_CR22","doi-asserted-by":"publisher","DOI":"10.2196\/26213","volume":"5","author":"PR Chai","year":"2021","unstructured":"Chai PR, et al. A brief training program to support the use of a digital pill system for medication adherence: pilot descriptive study. JMIR Form Res. 2021;5:e26213.","journal-title":"JMIR Form Res"},{"key":"5049_CR23","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.chb.2013.06.006","volume":"29","author":"LD Rosen","year":"2013","unstructured":"Rosen LD, Whaling K, Carrier LM, Cheever NA, Rokkum J. The media and technology usage and attitudes scale: an empirical investigation. Comput Human Behav. 2013;29:2501\u201311.","journal-title":"Comput Human Behav"},{"key":"5049_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","volume":"114","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, et al. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114:163\u201373.","journal-title":"J Affect Disord"},{"key":"5049_CR25","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092\u20137.","journal-title":"Arch Intern Med"},{"key":"5049_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1046\/j.1360-0443.2002.00185.x","volume":"97","author":"WHO Assist Working Group","year":"2002","unstructured":"WHO Assist Working Group. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97:1183\u201394.","journal-title":"Addiction"},{"key":"5049_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1540-5915.2008.00192.x","volume":"39","author":"V Venkatesh","year":"2008","unstructured":"Venkatesh V, Bala H. Technology acceptance model 3 and a research agenda on interventions. Decis Sci. 2008;39:273\u2013315.","journal-title":"Decis Sci"},{"key":"5049_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/16094069231184123","volume":"22","author":"RK Rosen","year":"2023","unstructured":"Rosen RK, et al. Use of framework matrix and thematic coding methods in qualitative analysis for mHealth: the FluidCalc app. Int J Qual Methods. 2023;22:16094069231184123.","journal-title":"Int J Qual Methods"},{"key":"5049_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103630","volume":"103","author":"S Maxwell","year":"2022","unstructured":"Maxwell S, Shahmanesh M, Gafos M. Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: a qualitative study. Int J Drug Policy. 2022;103:103630.","journal-title":"Int J Drug Policy"},{"key":"5049_CR30","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1007\/s10461-021-03200-4","volume":"25","author":"M van Dijk","year":"2021","unstructured":"van Dijk M, de Wit JBF, Guadamuz TE, Martinez JE, Jonas KJ. Slow uptake of PrEP: behavioral predictors and the influence of price on PrEP uptake among MSM with a high interest in PrEP. AIDS Behav. 2021;25:2382\u201390.","journal-title":"AIDS Behav"},{"key":"5049_CR31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12879-018-3463-4","volume":"18","author":"D Sidebottom","year":"2018","unstructured":"Sidebottom D, Ekstr\u00f6m AM, Str\u00f6mdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV \u2013 how can we improve uptake and adherence? BMC Infect Dis. 2018;18:581.","journal-title":"BMC Infect Dis"},{"key":"5049_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067549","volume":"13","author":"P Chai","year":"2023","unstructured":"Chai P, et al. Attitudes towards participating in research involving digital pill systems to measure oral HIV pre-exposure chemoprophylaxis: a cross-sectional study among men who have sex with men with substance use in the USA. BMJ Open. 2023;13:e067549.","journal-title":"BMJ Open"},{"key":"5049_CR33","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10461-018-2309-9","volume":"23","author":"C Grov","year":"2019","unstructured":"Grov C, Rendina HJ, John SA, Parsons JT. Determining the roles that club drugs, marijuana, and heavy drinking play in PrEP medication adherence among gay and bisexual men: implications for treatment and research. AIDS Behav. 2019;23:1277\u201386.","journal-title":"AIDS Behav"},{"key":"5049_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32014-8","volume":"13","author":"SA John","year":"2023","unstructured":"John SA, et al. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17\u201324 years old. Sci Rep. 2023;13:5116.","journal-title":"Sci Rep"},{"key":"5049_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s11524-022-00711-w","volume":"100","author":"AS Miller","year":"2023","unstructured":"Miller AS, Krakower DS, Mayer KH. The potential of long-acting, injectable PrEP, and impediments to its uptake. J Urban Health. 2023;100:212\u20134.","journal-title":"J Urban Health"},{"key":"5049_CR36","unstructured":"As remote patient monitoring expands, so does CPT to describe it. American Medical Association https:\/\/www.ama-assn.org\/practice-management\/cpt\/remote-patient-monitoring-expands-so-does-cpt-describe-it (2022)."},{"key":"5049_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/8755122520985219","volume":"37","author":"PR Chai","year":"2021","unstructured":"Chai PR, et al. Long-term stability of the electronic sensor component of a digital pill system in real-world storage settings. J Pharm Technol. 2021;37:135\u20139.","journal-title":"J Pharm Technol"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05049-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05049-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05049-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:32:41Z","timestamp":1784892761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05049-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5049"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05049-x","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"17 January 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PRC is funded by K23DA044874 and DP2DA056107. KM and CO are funded by P30AI060354. TRG\u2019s is funded by NIDA K23DA060719. TDF\/FTC as PrEP was provided for this study by Gilead Sciences (ISR-17-1018). PA, CC and EB are employees of eTectRx.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}